As of February 14, 2025, the amount of acute respiratory illness causing people to seek healthcare is at a high level. Seasonal influenza activity is higher than it has been all season. COVID-19 activity is elevated in many areas of the country.

Jan 7, 2025 · These increases are typically caused by seasonal epidemics of respiratory pathogens such as seasonal influenza, respiratory syncytial virus (RSV), and other common respiratory viruses, including human metapneumovirus (hMPV), as well as …

Several indicators illustrate the big global impact that acute respiratory infections (ARIs) have on public health, through morbidity and mortality.

This chapter deals with three aspects of the epidemiology of respiratory infections in children: common respiratory viruses, acute lower respiratory tract infection (ARI), and emerging/reemerging organisms.

Feb 14, 2025 · Respiratory illness activity is monitored using the acute respiratory illness (ARI) metric. ARI captures a broad range of diagnoses from emergency department visits for respiratory illnesses, from the common cold to severe infections like influenza, RSV and COVID-19.

Jul 1, 2024 · Here, we analyzed global data for respiratory viruses over nine consecutive seasons (2014-2022), showcasing the distinct virus-specific circulation, timing, and duration of epidemics by latitude-defined world areas.

Feb 1, 2020 · Several indicators illustrate the big global impact that acute respiratory infections (ARIs) have on public health, through morbidity and mortality.

Aug 30, 2024 · Acute respiratory infections (ARIs), including upper respiratory infections (URIs) and lower respiratory infections (LRIs), are characterized by symptoms such as cough, fever, nasal congestion, and, in severe cases, respiratory failure.

Feb 13, 2025 · Respiratory Virus Global Epidemiology Network (RSV GEN) We further reached out to members from RSV GEN to collect unpublished viral activity data 45,46. A total of 15 study sites had available ...

Dec 1, 2023 · The most frequent tested viruses were influenza virus (IV) (tested in 96,636 subjects) and human metapneumovirus (HMPV) (80,366 subjects) followed by human respiratory syncytial virus (HRSV) (56,263 subjects), human coronaviruses (HCoV) (48,478 subjects), enterovirus/rhinovirus (EV/RV) (44,391 subjects), human adenovirus (HAdV) (44,255 subjects ...